DrugCard

Tallinn, Estonia Founded: 2020 • Age: 6 yrs
Drug pharmacovigilance solutions are provided for pharmaceutical industries.
Request Access

About DrugCard

DrugCard is a company based in Tallinn (Estonia) founded in 2020.. DrugCard has raised $288.35 thousand across 3 funding rounds from investors including Google, Farmak and New Nordic Ventures. DrugCard operates in a competitive market with competitors including Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others.

  • Headquarter Tallinn, Estonia
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Drugcards Oü
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $288.35 K (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
    Google

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of DrugCard
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Christina Kiselova
Head Of Partnerships And Sales
People
Dmytro Horilyk
Chief Executive Officer
People
Ivan Savchenko
PHP Developer Symfony
People
Miroslav Demchun
Chief Technology Officer

Unlock access to complete

Funding Insights of DrugCard

DrugCard has successfully raised a total of $288.35K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (09 Dec 2021)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Seed - DrugCard Valuation New Nordic Ventures
Mar, 2022 Amount Grant - DrugCard Valuation

investors

Dec, 2021 Amount Seed - DrugCard Valuation Think Bigger Capital , Farmak
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in DrugCard

DrugCard has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Google, Farmak and New Nordic Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Seed-stage investments are made in Eastern European enterprise software startups.
Founded Year Domain Location
-
Founded Year Domain Location
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by DrugCard

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - DrugCard

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Drugcard Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DrugCard

DrugCard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-based pharmacovigilance platform is developed for report analysis and monitoring.
domain founded_year HQ Location
AI-based solutions for drug pharmacovigilance are provided.
domain founded_year HQ Location
Specialized pharmacovigilance software and services are developed and provided.
domain founded_year HQ Location
Adverse events and product quality are captured for life sciences.
domain founded_year HQ Location
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Drugcard

Frequently Asked Questions about DrugCard

When was DrugCard founded?

DrugCard was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is DrugCard located?

DrugCard is headquartered in Tallinn, Estonia.

Who is the current CEO of DrugCard?

Dmytro Horilyk is the current CEO of DrugCard.

Is DrugCard a funded company?

DrugCard is a funded company, having raised a total of $288.35K across 3 funding rounds to date. The company's 1st funding round was a Seed of $288.35K, raised on Dec 09, 2021.

What does DrugCard do?

DrugCard was founded in 2020 in Tallinn, Estonia, within the pharmaceutical sector. Software solutions are offered to support pharmacovigilance processes, including legal compliance management, data analysis, and AI-enabled decision-making tools. Pharmacovigilance services are also extended to organizations to aid in regulatory adherence and risk assessment across global operations.

Who are the top competitors of DrugCard?

DrugCard's top competitors include biologit, Sentrx and My Meds & Me.

Who are DrugCard's investors?

DrugCard has 4 investors. Key investors include Google, Farmak, New Nordic Ventures, and Think Bigger Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available